Clinical Trial Update: FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fecal microbiota transplant plus SOX chemotherapy and sintilimab as first-line treatment for advanced gastric cancer is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Fecal microbiota transplant (fecal microbiota transplant)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)
• Sintilimab (sintilimab)

Snippet

Sponsor: Changzhou No.2 People's Hospital | Conditions: Gastric Cancer | Phase 2 | Status: RECRUITING